Your session is about to expire
← Back to Search
Radiation
Systemic therapy plus SBRT to OM for Breast Cancer (STOMP Trial)
Phase < 1
Waitlist Available
Led By Anand Swaminath, MD,FRCPC
Research Sponsored by Juravinski Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3, 6 12 months from sbrt treatment
Awards & highlights
Summary
The purpose of this study is to evaluate feasibility to treat metachronous multi-site breast cancer oligometastasis with stereotactic body radiotherapy (SBRT) in patients on systemic therapy.
Eligible Conditions
- Breast Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3, 6 12 months from sbrt treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3, 6 12 months from sbrt treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Technical feasibility of planning SBRT to multiple sites
Secondary outcome measures
Feasibility of patient accrual: Successful accrual of 30 patients to study
Local Control: CT scan or MRI as assessed by RECIST criteria 1.1
Overall Survival (OS)
+3 moreSide effects data
From 2008 Phase 2 trial • 20 Patients • NCT0035014215%
ulcer
10%
vomiting
5%
Perforation
5%
pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
SBRT With Gem
Trial Design
1Treatment groups
Experimental Treatment
Group I: Systemic therapy plus SBRT to OMExperimental Treatment1 Intervention
Stereotactic Body Radiotherapy (SBRT) up to 5 OM sites
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Stereotactic Body Radiotherapy
2017
Completed Phase 2
~220
Find a Location
Who is running the clinical trial?
Toronto Sunnybrook Regional Cancer CentreOTHER
9 Previous Clinical Trials
923 Total Patients Enrolled
1 Trials studying Breast Cancer
24 Patients Enrolled for Breast Cancer
Juravinski Cancer CenterLead Sponsor
12 Previous Clinical Trials
2,279 Total Patients Enrolled
1 Trials studying Breast Cancer
630 Patients Enrolled for Breast Cancer
Anand Swaminath, MD,FRCPCPrincipal InvestigatorMcMaster University
Share this study with friends
Copy Link
Messenger